Compare Davita Inc (DVA) vs Hormel Foods Corp (HRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Hormel Foods Corp — how do they compare? Davita Inc trades at $178.34 (market cap $11.72B), while Hormel Foods Corp trades at $24.54 (market cap $13.59B). The key difference: Hormel Foods Corp is the larger of the two by market cap, and Hormel Foods Corp pays a 4.74% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | HRL | |
|---|---|---|
Market Cap | $11.72B | $13.59B |
Sector | Health | Consumer Staples |
52-Week High | $240.96 | $29.25 |
52-Week Low | $103.87 | $19.74 |
Enterprise Value | $24.44B | $15.59B |
Dividend Yield | — | 4.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Hormel Foods (HRL) trades at $25.02, down 0.32% on the day, with a neutral technical signal and bearish moving averages. The company shows mixed fundamentals with a P/E of 29.44 and net income margin of 3.82%, though it has beaten earnings estimates for three consecutive quarters. Recent developments include the appointment of John Ghingo as CEO and the sale of its Brazilian CERATTI business, signaling strategic focus.
Outlook remains cautious with analyst consensus at Hold and a $26.33 price target. Key opportunities include defensive dividend income and operational improvements, while risks involve margin pressure and consumer spending challenges. The stock offers steady income but faces growth headwinds in the current environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →
